Health
High Dose Favipiravir Countered SARS-CoV-2 in Hamsters, Hydroxychloroquine Ineffective – Global Biodefense
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters.
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by contrast, has an antiviral effect in the hamsters. The team published their findings in this week in the Proceedings of the National Academy of Sciences (PNAS).
Virologists at the KU Leuven Rega Institute have been working on two lines of SARS-CoV-2 research: searching for a vaccine to prevent …
-
General20 hours agoOf saints and sinners | The Spectator Australia
-
General21 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News11 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General21 hours agoWhy the nation needs the Nationals to ditch Net Zero